$BCRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in BIOCRYST PHARMACEUTICALS INC. Get notifications about new insider transactions in BIOCRYST PHARMACEUTICALS INC for free.

Page: 1 2 3 4 5 ... 9 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 01 2021	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	15.77	317	4,999	14,166	13.8 K to 14.2 K (+2.29 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	4.73	35,852	169,580	0
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	4.73	35,852	169,580	0
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	5.45	68,000	370,600	0
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	5.45	68,000	370,600	0
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	1.42	33,132	47,047	0
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	1.42	33,132	47,047	0
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	4.73	1,648	7,795	35,852
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Option Exercise	M	4.73	1,648	7,795	35,852
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	4.73	35,852	169,580	146,127	110.3 K to 146.1 K (+32.51 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	4.73	35,852	169,580	146,127	110.3 K to 146.1 K (+32.51 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Sell	S	12.04	102,780	1,237,471	110,275	213.1 K to 110.3 K (-48.24 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Sell	S	12.04	102,780	1,237,471	110,275	213.1 K to 110.3 K (-48.24 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	5.45	68,000	370,600	213,055	145.1 K to 213.1 K (+46.88 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	5.45	68,000	370,600	213,055	145.1 K to 213.1 K (+46.88 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	1.42	33,132	47,047	145,055	111.9 K to 145.1 K (+29.60 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	1.42	33,132	47,047	145,055	111.9 K to 145.1 K (+29.60 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	4.73	1,648	7,795	111,923	110.3 K to 111.9 K (+1.49 %)
May 13 2021	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Chief Legal Officer	Buy	M	4.73	1,648	7,795	111,923	110.3 K to 111.9 K (+1.49 %)
May 12 2021	BCRX	BIOCRYST PHARMACEU ...	ABERCROMBIE GEORGE B	Director	Sell	S	12.70	7,000	88,900	3,000	10 K to 3 K (-70.00 %)
Apr 02 2021	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Chief R&D Officer	Option Exercise	A	10.17	400,000	4,068,000	400,000
Apr 02 2021	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Chief R&D Officer	Grant	A	0.00	100,000	0	100,000	0 to 100 K
Mar 22 2021	BCRX	BIOCRYST PHARMACEU ...	Jones Michael L	Exec. Director, Fin ...	Option Exercise	M	3.51	4,500	15,795	0
Mar 22 2021	BCRX	BIOCRYST PHARMACEU ...	Jones Michael L	Exec. Director, Fin ...	Buy	M	3.51	4,500	15,795	5,348	848 to 5.3 K (+530.66 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	10.78	1,739	18,746	75,013	73.3 K to 75 K (+2.37 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	10.78	463	4,991	64,756	64.3 K to 64.8 K (+0.72 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	10.78	463	4,991	64,756	64.3 K to 64.8 K (+0.72 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	10.78	463	4,991	13,849	13.4 K to 13.8 K (+3.46 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	10.78	463	4,991	13,849	13.4 K to 13.8 K (+3.46 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	10.78	927	9,993	31,496	30.6 K to 31.5 K (+3.03 %)
Mar 02 2021	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	10.78	927	9,993	31,496	30.6 K to 31.5 K (+3.03 %)
Feb 24 2021	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	4.15	41,250	171,188	0
Feb 24 2021	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Sell	S	11.57	41,250	477,263	11,475	52.7 K to 11.5 K (-78.24 %)
Feb 24 2021	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	4.15	41,250	171,188	52,725	11.5 K to 52.7 K (+359.48 %)
Feb 23 2021	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	M	4.15	50,000	207,500	0
Feb 23 2021	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	11.53	22,431	258,629	183,156	205.6 K to 183.2 K (-10.91 %)
Feb 23 2021	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Buy	M	4.15	50,000	207,500	205,587	155.6 K to 205.6 K (+32.14 %)
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Sniecinski Megan	Chief Business Offi ...	Option Exercise	A	8.31	225,000	1,869,750	225,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Sniecinski Megan	Chief Business Offi ...	Option Exercise	A	8.31	225,000	1,869,750	225,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Jones Michael L	Exec. Director, Fin ...	Option Exercise	A	8.31	30,000	249,300	30,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Gayer Charles K	Vice President and ...	Option Exercise	A	8.31	190,000	1,578,900	190,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Option Exercise	A	8.31	280,000	2,326,800	280,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	8.31	280,000	2,326,800	280,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	8.31	335,000	2,783,850	335,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Doyle Anthony	Chief Financial Off ...	Option Exercise	A	8.31	332,500	2,763,075	332,500
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	8.31	870,000	7,229,700	870,000
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	M	4.15	134,278	557,254	1
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Sell	S	8.32	134,278	1,117,193	784,086	918.4 K to 784.1 K (-14.62 %)
Dec 17 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	M	4.15	134,278	557,254	918,364	784.1 K to 918.4 K (+17.13 %)
Dec 15 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Option Exercise	M	4.15	13,741	57,025	0
Dec 15 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Sell	S	7.96	13,741	109,378	108,061	121.8 K to 108.1 K (-11.28 %)
Dec 15 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Buy	M	4.15	13,741	57,025	121,802	108.1 K to 121.8 K (+12.72 %)
Dec 08 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Option Exercise	M	4.15	13,741	57,025	13,741
Dec 08 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Sell	S	6.23	13,741	85,606	108,061	121.8 K to 108.1 K (-11.28 %)
Dec 08 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Buy	M	4.15	13,741	57,025	121,802	108.1 K to 121.8 K (+12.72 %)
Dec 07 2020	BCRX	BIOCRYST PHARMACEU ...	Jones Michael L	Exec. Director, Fin ...	Option Exercise	A	5.45	5,000	27,250	5,000
Dec 07 2020	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 07 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 07 2020	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 07 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	3.23	157,250	507,918	157,250
Dec 07 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	5.45	25,000	136,250	25,000
Dec 02 2020	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	5.11	978	4,998	13,386	12.4 K to 13.4 K (+7.88 %)
Dec 02 2020	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	5.11	1,956	9,995	30,569	28.6 K to 30.6 K (+6.84 %)
Dec 02 2020	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	5.11	978	4,998	64,293	63.3 K to 64.3 K (+1.54 %)
Dec 02 2020	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	5.11	3,669	18,749	73,274	69.6 K to 73.3 K (+5.27 %)
Sep 02 2020	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	4.15	1,204	4,997	63,315	62.1 K to 63.3 K (+1.94 %)
Sep 02 2020	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	4.15	1,204	4,997	63,315	62.1 K to 63.3 K (+1.94 %)
Sep 02 2020	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	4.15	1,204	4,997	12,408	11.2 K to 12.4 K (+10.75 %)
Sep 02 2020	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	4.15	2,409	9,997	28,613	26.2 K to 28.6 K (+9.19 %)
Sep 02 2020	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	4.15	4,518	18,750	69,605	65.1 K to 69.6 K (+6.94 %)
Aug 12 2020	BCRX	BIOCRYST PHARMACEU ...	Doyle Anthony	Chief Financial Off ...	Buy	P	4.08	54,000	220,320	54,000	0 to 54 K
Jun 03 2020	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	4.50	1,112	4,998	11,204	10.1 K to 11.2 K (+11.02 %)
Jun 03 2020	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	4.50	4,171	18,749	65,087	60.9 K to 65.1 K (+6.85 %)
May 15 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	3.23	157,250	507,918	157,250
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	LEVIN ALAN G	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	LEE KENNETH B JR	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Option Exercise	A	5.41	40,000	216,400	40,000
May 04 2020	BCRX	BIOCRYST PHARMACEU ...	Doyle Anthony	Chief Financial Off ...	Option Exercise	A	3.91	600,000	2,346,000	600,000
Mar 03 2020	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	3.00	1,666	4,998	25,092	23.4 K to 25.1 K (+7.11 %)
Mar 03 2020	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	3.00	1,666	4,998	10,092	8.4 K to 10.1 K (+19.77 %)
Mar 03 2020	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	3.00	6,250	18,750	60,916	54.7 K to 60.9 K (+11.43 %)
Mar 03 2020	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	3.00	6,250	18,750	60,916	54.7 K to 60.9 K (+11.43 %)
Feb 25 2020	BCRX	BIOCRYST PHARMACEU ...	Jones Michael L	Exec. Director, Fin ...	Option Exercise	A	11.13	2,800	31,164	2,800
Feb 25 2020	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	11.13	18,000	200,340	18,000
Feb 25 2020	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	11.13	22,600	251,538	22,600
Feb 25 2020	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	11.13	18,000	200,340	18,000
Feb 25 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	12.16	27,140	330,022	27,140
Feb 19 2020	BCRX	BIOCRYST PHARMACEU ...	Jones Michael L	Exec. Director, Fin ...	Option Exercise	A	11.13	4,900	54,537	4,900
Feb 19 2020	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Option Exercise	A	11.13	21,700	241,521	21,700
Feb 19 2020	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	11.13	31,500	350,595	31,500
Feb 19 2020	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	11.13	31,500	350,595	31,500
Feb 19 2020	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	12.16	47,495	577,539	47,495
Dec 19 2019	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Option Exercise	A	3.23	190,000	613,700	190,000
Dec 19 2019	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	3.23	225,000	726,750	225,000
Dec 19 2019	BCRX	BIOCRYST PHARMACEU ...	Sniecinski Megan	Chief Business Offi ...	Option Exercise	A	3.23	202,000	652,460	202,000
Dec 19 2019	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	3.23	176,000	568,480	176,000
Dec 19 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	3.23	165,000	532,950	165,000
Dec 19 2019	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	3.23	314,500	1,015,835	314,500
Dec 03 2019	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	2.85	1,754	4,999	8,426	6.7 K to 8.4 K (+26.29 %)
Dec 03 2019	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	2.85	1,754	4,999	23,426	21.7 K to 23.4 K (+8.09 %)
Dec 03 2019	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	2.85	3,508	9,998	56,554	53 K to 56.6 K (+6.61 %)
Dec 03 2019	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	2.85	6,578	18,747	54,666	48.1 K to 54.7 K (+13.68 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	P	1.45	50,000	72,500	778,086	728.1 K to 778.1 K (+6.87 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	Sniecinski Megan	Chief Business Offi ...	Buy	P	1.45	45,000	65,250	45,000	0 to 45 K
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	LEE KENNETH B JR	Director	Buy	P	1.45	5,000	7,250	15,252	10.3 K to 15.3 K (+48.77 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Buy	P	1.45	20,000	29,000	48,088	28.1 K to 48.1 K (+71.20 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Buy	P	1.45	10,000	14,500	53,046	43 K to 53 K (+23.23 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Buy	P	1.45	5,000	7,250	6,672	1.7 K to 6.7 K (+299.04 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	Senior VP, Chief Le ...	Buy	P	1.45	20,000	29,000	102,061	82.1 K to 102.1 K (+24.37 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Buy	P	1.45	25,000	36,250	155,587	130.6 K to 155.6 K (+19.14 %)
Nov 18 2019	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Buy	P	1.45	15,000	21,750	21,672	6.7 K to 21.7 K (+224.82 %)
Sep 24 2019	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Director	Option Exercise	A	2.86	40,000	114,400	40,000
Sep 04 2019	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Grant	A	2.99	1,672	4,999	1,672	0 to 1.7 K
Sep 04 2019	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Grant	A	2.99	1,672	4,999	6,672	5 K to 6.7 K (+33.44 %)
Sep 04 2019	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	2.99	3,344	9,999	43,046	39.7 K to 43 K (+8.42 %)
Sep 04 2019	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	2.99	6,270	18,747	28,088	21.8 K to 28.1 K (+28.74 %)
Jul 03 2019	BCRX	BIOCRYST PHARMACEU ...	Sniecinski Megan	Chief Business Offi ...	Option Exercise	A	3.71	500,000	1,855,000	500,000
May 31 2019	BCRX	BIOCRYST PHARMACEU ...	LEE KENNETH B JR	Director	Option Exercise	A	2.91	30,000	87,300	30,000
May 31 2019	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Option Exercise	A	2.91	30,000	87,300	30,000
May 31 2019	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Option Exercise	A	2.91	30,000	87,300	30,000
May 31 2019	BCRX	BIOCRYST PHARMACEU ...	HEGGIE THERESA	Director	Option Exercise	A	2.91	30,000	87,300	30,000
May 31 2019	BCRX	BIOCRYST PHARMACEU ...	ABERCROMBIE GEORGE B	Director	Option Exercise	A	2.91	30,000	87,300	30,000
May 24 2019	BCRX	BIOCRYST PHARMACEU ...	ASELAGE STEVE	Director	Buy	P	3.57	3,000	10,710	5,000	2 K to 5 K (+150.00 %)
May 20 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	1.42	4,750	6,745	61,000
May 20 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.45	2,500	18,625	125,176	127.7 K to 125.2 K (-1.96 %)
May 20 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.72	7,250	55,970	127,676	134.9 K to 127.7 K (-5.37 %)
May 20 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	1.42	4,750	6,745	134,926	130.2 K to 134.9 K (+3.65 %)
May 16 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	1.42	4,750	6,745	65,750
May 16 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	1.42	4,500	6,390	70,500
May 16 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.92	7,250	57,420	130,176	137.4 K to 130.2 K (-5.28 %)
May 16 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	1.42	4,750	6,745	137,426	132.7 K to 137.4 K (+3.58 %)
May 16 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.62	4,500	34,290	132,676	137.2 K to 132.7 K (-3.28 %)
May 16 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	1.42	4,500	6,390	137,176	132.7 K to 137.2 K (+3.39 %)
May 13 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	5.51	9,750	53,723	131,250
May 13 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	5.51	9,750	53,723	141,000
May 13 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.76	9,750	75,660	132,676	142.4 K to 132.7 K (-6.85 %)
May 13 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	5.51	9,750	53,723	142,426	132.7 K to 142.4 K (+7.35 %)
May 13 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.63	9,750	74,393	132,676	142.4 K to 132.7 K (-6.85 %)
May 13 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	5.51	9,750	53,723	142,426	132.7 K to 142.4 K (+7.35 %)
May 06 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	5.51	9,000	49,590	150,750
May 06 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	5.51	7,750	42,703	159,750
May 06 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.75	9,000	69,750	132,676	141.7 K to 132.7 K (-6.35 %)
May 06 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	5.51	9,000	49,590	141,676	132.7 K to 141.7 K (+6.78 %)
May 06 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.30	7,750	56,575	132,676	140.4 K to 132.7 K (-5.52 %)
May 06 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	5.51	7,750	42,703	140,426	132.7 K to 140.4 K (+5.84 %)
Apr 08 2019	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	5.51	7,500	41,325	167,500

Page: 1 2 3 4 5 ... 9 next >